Pulmonology
Lung Cancer
More in Lung Cancer
Also in TTHealthWatch: improving outcomes in large strokes
Health news and commentary gathered by 番茄社区app staff
Greater burden of disease in younger folks and women, American Cancer Society projects
An integrated intervention had the greatest impact in a randomized trial
Score based on pathology images an independent predictor of PFS, OS
In randomized study, ensartinib doubled PFS versus first-generation ALK inhibitor
Signal largely driven by newly emerging arrhythmias
Prevention and screening efforts accounted for 80% of those averted deaths
Unprecedented 22.5-month improvement in median overall survival as consolidation therapy
Zenocutuzumab achieved response rates of 40% in pancreatic adenocarcinoma, 33% in advanced NSCLC
A look back at some of the newsworthy developments of 2024
